Skip to content
x
Home
Program
Speakers
Start-up pitch
Poster Presentation
Registration
On Site
Sponsors and exhibitors
History
2022
Impressions
Program
2021
Speakers
2020
Program 2020
2019
Home
Program
Speakers
Start-up pitch
Poster Presentation
Registration
On Site
Sponsors and exhibitors
History
2022
Impressions
Program
2021
Speakers
2020
Program 2020
2019
AMR pull incentives | Will COVID-19 speed up or slow down implementation?
AMR pull incentives | Will COVID-19 speed up or slow down implementation?
Moderator:
Kathy Talkington, Director Health Programs, Pew Charitable Trust
Speakers:
Suzanne Edwards – Programme Officer/Economist,
Global AMR R&D Hub
This content has been restricted to logged in users only. Please
login
to view this content.
Kevin Outterson – Professor of Law & Executive Director,
CARB-X
This content has been restricted to logged in users only. Please
login
to view this content.
Colm Leonard – Clinical Advisor/Consultant, NICE
This content has been restricted to logged in users only. Please
login
to view this content.
Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta
This content has been restricted to logged in users only. Please
login
to view this content.
Play Video
This might also be of interest for you:
Pew Trust: Take Action: Antibiotic resistance is a looming threat.
Urge Your Senators to act
Nature Magazine, 11 August:
Pharmaceutical firms commit US$1 billion to antibiotic development
Stat News, 12th August, by Kevin Outterson:
We need new antimicrobials to prevent the next infectious disease crisis
ACS Infect. Dis. 2020: Viewpoint, 12 June: By Wes Kim, The Pew Charitable Trust:
On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away
Explore these AMR Stakeholder Guide profiles:
Global AMR R&D Hub
,
CARB-X